Riggs B. Rory's Insider Trades & SAST Disclosures
Riggs B. Rory's most recent trade in Cibus Inc - Ordinary Shares - Class A was a trade of 4,000,000 Pre-Funded Warrant done . Disclosure was reported to the exchange on Jan. 21, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Riggs B. Rory.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 4,000,000 | 4,000,000 | - | - | Pre-Funded Warrant | |
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2025 | 4,000,000 | 4,000,000 | - | - | Common Warrant | |
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 31 Dec 2024 | 1,388,084 | 0 | - | - | Class B Common Stock | ||
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 31 Dec 2024 | 1,388,084 | 0 | - | - | Cibus Common Unit | ||
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 31 Dec 2024 | 1,388,084 | 4,839,912 (14%) | 4% | - | Class A Common Stock | ||
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 83.52 per share. | 31 Dec 2024 | 215 | 131,512 (0%) | 0% | 83.5 | 17,957 | Common Stock |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 73.17 per share. | 30 Sep 2024 | 246 | 117,108 (0%) | 0% | 73.2 | 18,000 | Common Stock |
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 4.00 per share. | 18 Sep 2024 | 250,000 | 3,451,828 (10%) | 0% | 4 | 1,000,000 | Class A Common Stock |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 68.49 per share. | 28 Jun 2024 | 262 | 116,862 (0%) | 0% | 68.5 | 17,944 | Common Stock |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 16.86 per share. | 23 Jun 2024 | 20,000 | 121,062 (0%) | 0% | 16.9 | 337,200 | Common Stock |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 75.57 per share. | 23 Jun 2024 | 4,462 | 116,600 (0%) | 0% | 75.6 | 337,193 | Common Stock |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 0 | - | - | Restricted Stock Units | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Jun 2024 | 1,567 | 101,062 (0%) | 0% | - | Common Stock | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 4,322 | 4,322 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 2,951 | 2,951 | - | - | Restricted Stock Units | |
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 98,040 | 98,040 | - | - | Common Warrant | |
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 10.20 per share. | 11 Jun 2024 | 98,040 | 3,201,828 (9%) | 0% | 10.2 | 1,000,008 | Class A Common Stock |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 69.20 per share. | 31 Mar 2024 | 260 | 99,495 (0%) | 0% | 69.2 | 17,992 | Common Stock |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2024 | 20,000 | 0 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 18.56 per share. | 20 Mar 2024 | 20,000 | 99,235 (0%) | 0% | 18.6 | 371,200 | Common Stock |
| Royalty Pharma plc - Ordin... | B. Riggs Rory | Director | 20 Feb 2024 | 300,000 | 320,099 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Rory Riggs B. | Director | 20 Feb 2024 | 30,000 | 270,000 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 28.52 per share. | 02 Jan 2024 | 235,200 | 254,899 | - | 28.5 | 6,707,081 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Riggs B. Rory | Director | Sale of securities on an exchange or to another person at price $ 27.79 per share. | 02 Jan 2024 | 199,098 | 55,801 | - | 27.8 | 5,532,276 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Riggs B. Rory | Director | Sale of securities on an exchange or to another person at price $ 27.55 per share. | 02 Jan 2024 | 35,702 | 20,099 | - | 27.5 | 983,504 | Class A Ordinary Shares |
| Intra-Cellular Therapies Inc | B. Riggs Rory | Director | Grant, award, or other acquisition of securities at price $ 71.62 per share. | 31 Dec 2023 | 251 | 79,235 (0%) | 0% | 71.6 | 17,977 | Common Stock |
| Cibus Inc - Ordinary Share... | Riggs Rory B. | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 1,505,967 | 2,867,193 | - | - | Cibus Common Units | |
| Cibus Inc - Ordinary Share... | B. Rory Riggs | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 29 Dec 2023 | 1,505,967 | 2,867,193 | - | 0 | Class B Common Stock | |
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | 29 Dec 2023 | 1,500,000 | 1,367,193 | - | - | Cibus Common Units | ||
| Cibus Inc - Ordinary Share... | Riggs Rory B. | Director, Chief Executive Officer, Ten Percent Owner | 29 Dec 2023 | 1,500,000 | 3,103,788 (9%) | 4% | 0 | Class A Common Stock | ||
| Cibus Inc - Ordinary Share... | B. Rory Riggs | Director, Chief Executive Officer, Ten Percent Owner | 29 Dec 2023 | 1,500,000 | 1,367,193 | - | 0 | Class B Common Stock | ||
| Cibus Inc - Ordinary Share... | B. Riggs Rory | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 10.58 per share. | 12 Dec 2023 | 517,107 | 1,622,495 (4%) | 1% | 10.6 | 5,470,992 | Class A Common Stock |
| Cibus Inc - Ordinary Share... | Rory B. Riggs | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 50,000 | 50,000 | - | - | Pre-Funded Warrant | |
| Cibus Inc - Ordinary Share... | B. Rory Riggs | Director, Chief Executive Officer, Ten Percent Owner | Other type of transaction at price $ 0.00 per share. | 12 Dec 2023 | 39,476 | 1,105,388 (3%) | 0% | 0 | Class A Common Stock | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Aug 2023 | 6,500 | 347,559 | - | - | LP interests in RPI US Partners 2019, LP | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 63.32 per share. | 30 Jun 2023 | 279 | 78,639 (0%) | 0% | 63.3 | 17,666 | Common Stock |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,747 | 14,509 | - | 0 | Class A Ordinary Shares | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 7,009 | 7,009 | - | - | Stock Option (right to buy) | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jun 2023 | 1,567 | 1,567 | - | - | Restricted Stock Units | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 32.82 per share. | 22 May 2023 | 1,750,000 | 6,762 | - | 32.8 | 57,435,000 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | 09 May 2023 | 300,000 | 1,756,762 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | 09 May 2023 | 30,000 | 354,059 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 54.15 per share. | 31 Mar 2023 | 313 | 78,360 (0%) | 0% | 54.2 | 16,949 | Common Stock |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 36.26 per share. | 29 Mar 2023 | 130,024 | 1,456,762 | - | 36.3 | 4,714,345 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 36.95 per share. | 29 Mar 2023 | 9,926 | 1,586,786 | - | 37.0 | 366,766 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | 17 Feb 2023 | 1,500,000 | 1,596,712 | - | 0 | Class A Ordinary Shares | ||
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | 17 Feb 2023 | 150,000 | 384,059 | - | - | LP interests in RPI US Partners 2019, LP | ||
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 52.92 per share. | 30 Dec 2022 | 321 | 78,047 (0%) | 0% | 52.9 | 16,987 | Common Stock |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 41.98 per share. | 09 Dec 2022 | 40,010 | 96,712 | - | 42.0 | 1,679,684 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.07 per share. | 09 Dec 2022 | 19,990 | 136,722 | - | 42.1 | 840,939 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.33 per share. | 17 Nov 2022 | 120,000 | 156,712 | - | 42.3 | 5,079,924 | Class A Ordinary Shares |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 46.53 per share. | 30 Sep 2022 | 365 | 77,726 (0%) | 0% | 46.5 | 16,983 | Common Stock |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.21 per share. | 14 Sep 2022 | 52,025 | 276,712 | - | 42.2 | 2,195,960 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.41 per share. | 14 Sep 2022 | 47,975 | 328,737 | - | 42.4 | 2,034,428 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 43.73 per share. | 09 Aug 2022 | 45,000 | 376,712 | - | 43.7 | 1,967,823 | Class A Ordinary Shares |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 57.08 per share. | 30 Jun 2022 | 289 | 77,361 (0%) | 0% | 57.1 | 16,496 | Common Stock |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.17 per share. | 29 Jun 2022 | 30,000 | 421,712 | - | 42.2 | 1,265,238 | Class A Ordinary Shares |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2022 | 16,757 | 16,757 | - | - | Stock Option (right to buy) | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 39.28 per share. | 19 May 2022 | 123,696 | 451,712 | - | 39.3 | 4,858,655 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 40.09 per share. | 19 May 2022 | 26,304 | 575,408 | - | 40.1 | 1,054,651 | Class A Ordinary Shares |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 61.19 per share. | 31 Mar 2022 | 257 | 77,072 (0%) | 0% | 61.2 | 15,726 | Common Stock |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 38.59 per share. | 29 Mar 2022 | 60,000 | 601,712 | - | 38.6 | 2,315,322 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 17 Mar 2022 | 1,075,178 | 40,560 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 17 Mar 2022 | 531,684 | 141,368 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 17 Mar 2022 | 229,626 | 72,348 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 17 Mar 2022 | 64,067 | 661,712 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 39.77 per share. | 17 Mar 2022 | 56,181 | 85,187 | - | 39.8 | 2,234,094 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 39.38 per share. | 17 Mar 2022 | 46,803 | 25,545 | - | 39.4 | 1,843,247 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 39.38 per share. | 17 Mar 2022 | 26,238 | 14,322 | - | 39.4 | 1,033,334 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 39.05 per share. | 17 Mar 2022 | 25,545 | 0 | - | 39.1 | 997,558 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 39.05 per share. | 17 Mar 2022 | 14,322 | 0 | - | 39.1 | 559,288 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 17 Mar 2022 | 4,897 | 597,645 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Dec 2021 | 707,155 | 1,142,415 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Dec 2021 | 407,400 | 708,245 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Dec 2021 | 150,997 | 349,552 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 28 Dec 2021 | 75,000 | 592,748 | - | 40.0 | 3,000,353 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 40.21 per share. | 28 Dec 2021 | 47,578 | 301,974 | - | 40.2 | 1,912,893 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Dec 2021 | 42,138 | 667,748 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 40.21 per share. | 28 Dec 2021 | 35,193 | 673,052 | - | 40.2 | 1,414,963 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 40.21 per share. | 28 Dec 2021 | 26,677 | 1,115,738 | - | 40.2 | 1,072,559 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Dec 2021 | 3,212 | 625,610 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 16 Nov 2021 | 1,028,973 | 1,888,385 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 16 Nov 2021 | 612,668 | 1,146,986 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 16 Nov 2021 | 219,710 | 569,782 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.35 per share. | 16 Nov 2021 | 69,233 | 500,549 | - | 42.3 | 2,931,900 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.39 per share. | 16 Nov 2021 | 62,435 | 622,398 | - | 42.4 | 2,646,401 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 16 Nov 2021 | 61,338 | 697,398 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.35 per share. | 16 Nov 2021 | 38,815 | 1,849,570 | - | 42.3 | 1,643,749 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.33 per share. | 16 Nov 2021 | 31,341 | 1,115,645 | - | 42.3 | 1,326,636 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 42.01 per share. | 16 Nov 2021 | 12,565 | 684,833 | - | 42.0 | 527,805 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 16 Nov 2021 | 4,674 | 636,060 | - | - | Class A Ordinary Shares | |
| Intra-Cellular Therapies Inc | Rory B. Riggs | Director | Grant, award, or other acquisition of securities at price $ 37.28 per share. | 30 Sep 2021 | 422 | 76,515 (0%) | 0% | 37.3 | 15,732 | Common Stock |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Sep 2021 | 511,727 | 2,917,358 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Sep 2021 | 314,886 | 1,759,654 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Sep 2021 | 109,814 | 789,492 | - | - | Class A Ordinary Shares | |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 36.75 per share. | 28 Sep 2021 | 40,000 | 639,760 | - | 36.8 | 1,470,088 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 36.31 per share. | 28 Sep 2021 | 34,604 | 899,306 | - | 36.3 | 1,256,623 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 36.50 per share. | 28 Sep 2021 | 24,648 | 615,112 | - | 36.5 | 899,706 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Sale of securities on an exchange or to another person at price $ 36.31 per share. | 28 Sep 2021 | 22,173 | 3,429,085 | - | 36.3 | 805,199 | Class A Ordinary Shares |
| Royalty Pharma plc - Ordin... | Rory B. Riggs | Director | Other type of transaction at price $ 0.00 per share. | 28 Sep 2021 | 8,641 | 631,386 | - | - | Class A Ordinary Shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges